A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced.

Scientist Kate Adamala doesn’t remember exactly when she realized her lab at the University of Minnesota was working on something potentially dangerous — so dangerous in fact that some researchers ...